CareMax Management
Management criteria checks 2/4
CareMax's CEO is Carlos de Solo, appointed in May 2011, has a tenure of 13.67 years. total yearly compensation is $3.39M, comprised of 19.2% salary and 80.8% bonuses, including company stock and options. directly owns 5.65% of the company’s shares, worth $5.39K. The average tenure of the management team and the board of directors is 2.8 years and 2.9 years respectively.
Key information
Carlos de Solo
Chief executive officer
US$3.4m
Total compensation
CEO salary percentage | 19.2% |
CEO tenure | 13.7yrs |
CEO ownership | 5.6% |
Management average tenure | 2.8yrs |
Board average tenure | 2.9yrs |
Recent management updates
Recent updates
US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results
Aug 14CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity
Jun 20Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results
May 13Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%
Mar 11CareMax: Numbers Are Strong, Compelling Value On Offer
Sep 16CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M
Aug 09CareMax: Steward Health Care Acquisition Highlights Growth Ambitions
Jul 02CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$783m |
Mar 31 2024 | n/a | n/a | -US$645m |
Dec 31 2023 | US$3m | US$650k | -US$683m |
Sep 30 2023 | n/a | n/a | -US$207m |
Jun 30 2023 | n/a | n/a | -US$126m |
Mar 31 2023 | n/a | n/a | -US$103m |
Dec 31 2022 | US$3m | US$650k | -US$38m |
Sep 30 2022 | n/a | n/a | -US$52m |
Jun 30 2022 | n/a | n/a | -US$44m |
Mar 31 2022 | n/a | n/a | -US$25m |
Dec 31 2021 | US$2m | US$419k | -US$7m |
Sep 30 2021 | n/a | n/a | -US$2m |
Jun 30 2021 | n/a | n/a | US$12m |
Mar 31 2021 | n/a | n/a | US$6m |
Dec 31 2020 | US$3m | US$112k | US$8m |
Sep 30 2020 | n/a | n/a | US$7m |
Dec 31 2019 | US$3m | US$48k | US$6m |
Compensation vs Market: Carlos's total compensation ($USD3.39M) is above average for companies of similar size in the US market ($USD642.68K).
Compensation vs Earnings: Carlos's compensation has been consistent with company performance over the past year.
CEO
Carlos de Solo (45 yo)
13.7yrs
Tenure
US$3,386,890
Compensation
Mr. Carlos A. de Solo is a Co-Founder of CareMax Medical Group, L.L.C., and serves as President, Chief Executive Officer and Director since May 2011. Mr. de Solo has experience in the healthcare industry....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 13.7yrs | US$3.39m | 5.65% $ 5.4k | |
Executive VP | 3.6yrs | US$1.35m | 0.14% $ 138.0 | |
Executive VP & COO | 13.7yrs | US$1.82m | 2.55% $ 2.4k | |
Chief Accounting Officer | 3yrs | no data | no data | |
Chief Administrative Officer & Head of MSO Operations | 1.8yrs | no data | no data | |
SVP of Finance & Investor Relations | no data | no data | no data | |
Senior VP | 2.8yrs | no data | no data | |
Chief Compliance Officer | 2.8yrs | no data | no data | |
Chief Medical Officer & President of Caremax MSO | no data | no data | no data | |
Chief Experience Officer | 2.8yrs | no data | no data | |
Chief Digital Officer | 2yrs | no data | no data | |
Chief Restructuring Officer | less than a year | no data | no data |
2.8yrs
Average Tenure
45yo
Average Age
Experienced Management: CMAX.Q's management team is considered experienced (2.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 13.7yrs | US$3.39m | 5.65% $ 5.4k | |
Advisor to the Board | 2.9yrs | US$565.56k | no data | |
Independent Director | less than a year | no data | no data | |
Director | 2.2yrs | US$205.00k | 15.79% $ 15.1k | |
Independent Director | 2.2yrs | US$216.35k | 0.011% $ 10.1 | |
Independent Director | 3.5yrs | US$235.00k | 0.47% $ 449.7 | |
Independent Chairman | 3.6yrs | US$322.50k | 0.036% $ 34.5 | |
Independent Director | 3.6yrs | US$205.00k | 0.026% $ 24.7 | |
Independent Director | 2.2yrs | US$225.00k | 0.011% $ 10.1 |
2.9yrs
Average Tenure
57yo
Average Age
Experienced Board: CMAX.Q's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/06 05:26 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CareMax, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Brian Tanquilut | Jefferies LLC |
Jessica Tassan | Piper Sandler Companies |
Gary Taylor | TD Cowen |